On Friday, CAMP4 Therapeutics Corp (NASDAQ: CAMP) opened higher 2.70% from the last session, before settling in for the closing price of $1.48. Price fluctuations for CAMP have ranged from $1.30 to $12.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 78.64% at the time writing. With a float of $2.64 million, this company’s outstanding shares have now reached $20.16 million.
CAMP4 Therapeutics Corp (CAMP) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CAMP4 Therapeutics Corp is 86.90%, while institutional ownership is 8.11%. The most recent insider transaction that took place on Oct 15 ’24, was worth 8,399,996. In this transaction 10% Owner of this company bought 763,636 shares at a rate of $11.00, taking the stock ownership to the 763,636 shares. Before that another transaction happened on Oct 15 ’24, when Company’s 10% Owner bought 727,272 for $11.00, making the entire transaction worth $7,999,992. This insider now owns 1,579,885 shares in total.
CAMP4 Therapeutics Corp (CAMP) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -24.19 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.17) by -23.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 78.64% per share during the next fiscal year.
CAMP4 Therapeutics Corp (NASDAQ: CAMP) Trading Performance Indicators
Check out the current performance indicators for CAMP4 Therapeutics Corp (CAMP). In the past quarter, the stock posted a quick ratio of 5.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.57, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of CAMP4 Therapeutics Corp (CAMP)
CAMP4 Therapeutics Corp (NASDAQ: CAMP) saw its 5-day average volume 56540.0, a negative change from its year-to-date volume of 0.16 million. As of the previous 9 days, the stock’s Stochastic %D was 13.68%.
During the past 100 days, CAMP4 Therapeutics Corp’s (CAMP) raw stochastic average was set at 12.68%, which indicates a significant decrease from 28.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1678 in the past 14 days, which was lower than the 0.1942 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5567, while its 200-day Moving Average is $3.6014. Nevertheless, the first resistance level for the watch stands at $1.5833 in the near term. At $1.6467, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7233. If the price goes on to break the first support level at $1.4433, it is likely to go to the next support level at $1.3667. Assuming the price breaks the second support level, the third support level stands at $1.3033.
CAMP4 Therapeutics Corp (NASDAQ: CAMP) Key Stats
There are currently 20,161K shares outstanding in the company with a market cap of 30.64 million. Presently, the company’s annual sales total 650 K according to its annual income of -51,790 K. Last quarter, the company’s sales amounted to 1,500 K and its income totaled -12,590 K.
